Bibliometric Evaluation of Publications (2000-2020) on the Prognosis of Gastric Cancer

Overview

Journal Inquiry

Specialties Health Services
Public Health

Date 2021 Dec 8

PMID 34875913

Citations 1

Authors

Yujie Zhang

Chaoran Yu

Affiliations

Soon will be listed here.

Abstract

: Gastric cancer remains a global malignancy. The role of bibliometric analysis is increasingly valued. It is feasible and necessary to perform a bibliometric analysis to regurgitate studies in the prognosis of gastric cancer. : Web of Science was selected for the dataset resource. Articles published between 2000 and 2020 within the database of Web of Science Core Collection were included with predefined search terms. CiteSpace version 5.7.R1 and R software program version 4.0.3 were used for bibliometric analysis with parameters extrapolated from included studies. : A total of 1721 articles were included from 2000 to 2020 with remarkably increasing trends. China (n=1183), Japan (n=218), and South Korea (n=119) showed the most publications. SUN YAT SEN University, FUDAN University, and NANJING MED University were the top institutions with most publications. Keywords with strongest citation bursts between 2000 and 2020 were characterized. Particularly, "statistics", "resistance", "mortality", "lncrna", "diagnosis", "outcome", "migration", "promote," and "regulatory t cell" were the latest rising keywords since 2017, indicating possible study trends ahead. Several articles showed strongest citation bursts, including Jemal A. CA-CANCER J CLIN, Van Cutsem E. LANCET, and Japanese Gastric Cancer Association GASTRIC CANCER. : This bibliometric analysis provides a thought-provoking, insightful result concerning the trajectory of research development in prognosis of gastric cancer with a future perspective.

Citing Articles

Research Hotspots in Psoriasis: A Bibliometric Study of the Top 100 Most Cited Articles.

Tiuca O, Morariu S, Mariean C, Tiuca R, Nicolescu A, Cotoi O Healthcare (Basel). 2023; 11(13).

PMID: 37444683 PMC: 10340654. DOI: 10.3390/healthcare11131849.

References

. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2016; 20(1):1-19. PMC: 5215069. DOI: 10.1007/s10120-016-0622-4. View

Chaudhary B, Elkord E . Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel). 2016; 4(3). PMC: 5041022. DOI: 10.3390/vaccines4030028. View

Hirsch J . An index to quantify an individual's scientific research output. Proc Natl Acad Sci U S A. 2005; 102(46):16569-72. PMC: 1283832. DOI: 10.1073/pnas.0507655102. View

Ellegaard O, Wallin J . The bibliometric analysis of scholarly production: How great is the impact?. Scientometrics. 2015; 105(3):1809-1831. PMC: 4643120. DOI: 10.1007/s11192-015-1645-z. View

Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin. 2011; 61(2):69-90. DOI: 10.3322/caac.20107. View

Hamashima C . Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn J Clin Oncol. 2018; 48(7):673-683. DOI: 10.1093/jjco/hyy077. View

Tomita Y, Moldovan M, Chang Lee R, Hsieh A, Townsend A, Price T . Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. Cochrane Database Syst Rev. 2020; 11:CD012078. PMC: 8094513. DOI: 10.1002/14651858.CD012078.pub2. View

Liu X, Lin X, Mei Y, Ahmad S, Yan C, Jin H . Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer. Front Immunol. 2019; 10:1741. PMC: 6682668. DOI: 10.3389/fimmu.2019.01741. View

Smyth E, Nilsson M, Grabsch H, van Grieken N, Lordick F . Gastric cancer. Lancet. 2020; 396(10251):635-648. DOI: 10.1016/S0140-6736(20)31288-5. View

10.

Johnston F, Beckman M . Updates on Management of Gastric Cancer. Curr Oncol Rep. 2019; 21(8):67. DOI: 10.1007/s11912-019-0820-4. View

11.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

12.

Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H . Gastric cancer. Lancet. 2016; 388(10060):2654-2664. DOI: 10.1016/S0140-6736(16)30354-3. View

13.

Powell A, Hughes D, Wheat J, Lewis W . The 100 most influential manuscripts in gastric cancer: A bibliometric analysis. Int J Surg. 2016; 28:83-90. DOI: 10.1016/j.ijsu.2016.02.028. View

14.

Facciabene A, Motz G, Coukos G . T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012; 72(9):2162-71. PMC: 3342842. DOI: 10.1158/0008-5472.CAN-11-3687. View

15.

Tsugane S, Sasazuki S . Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007; 10(2):75-83. DOI: 10.1007/s10120-007-0420-0. View

16.

Arnold M, Park J, Camargo M, Lunet N, Forman D, Soerjomataram I . Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020; 69(5):823-829. PMC: 8520492. DOI: 10.1136/gutjnl-2019-320234. View

17.

Liu X, Yu H, Yan C, Mei Y, Lin C, Hong Y . Plasmacytoid Dendritic Cells and ICOS Regulatory T Cells Predict Poor Prognosis in Gastric Cancer: A Pilot Study. J Cancer. 2019; 10(26):6711-6715. PMC: 6856898. DOI: 10.7150/jca.34826. View

18.

Brenner H, Rothenbacher D, Arndt V . Epidemiology of stomach cancer. Methods Mol Biol. 2008; 472:467-77. DOI: 10.1007/978-1-60327-492-0_23. View

19.

Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M . Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures. Cancer Immunol Res. 2019; 7(5):737-750. DOI: 10.1158/2326-6066.CIR-18-0436. View

20.

Lin J . Screening of gastric cancer: who, when, and how. Clin Gastroenterol Hepatol. 2013; 12(1):135-8. DOI: 10.1016/j.cgh.2013.09.064. View